From: Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery
 | Historical control cohort (n = 533) | PLV cohort (n = 558) | P value |
---|---|---|---|
Length of hospital stay (days) | 14.5 (3.3) | 11.8 (4.1)* | < 0.001 |
Admission to the intensive care unit (%) | 9.4 | 2.5* | < 0.001 |
Mortality (%) | 2.8 | 2.3 | 0.753 |
Reoperation (%) | 1.0 | 1.6 | 0.687 |
Respiratory complications (%) | 14.4 | 10.8 | 0.080 |
   Atelectasis | 8.8 | 5.0* | 0.018 |
   Pneumonia | 5.6 | 4.1 | 0.309 |
   Bronchopleural fistula | 1.5 | 1.3 | 0.873 |
   Acute lung injury | 3.8 | 0.9* | 0.032 |
Pneumonectomy | 10.7 | 3.1 | 0.094 |
Lobectomy, bi-lobectomy | 1.7 | 0.2 | 0.174 |
Lesser resection | 3.8 | 0.7 | 0.282 |
   Mechanical ventilation >24 hours | 4.1 | 3.5 | 0.379 |
Cardiovascular complications (%) | 12.0 | 11.3 | 0.723 |
   Myocardial infarct | 1.3 | 0.9 | 0.711 |
   Heart failure | 0.9 | 1.4 | 0.635 |
   Stroke | 0.8 | 0.7 | 0.951 |
   Arrhythmia's | 11.8 | 10.4 | 0.514 |
Renal dysfunction | 5.1 | 3.0 | 0.123 |